Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 03, 2024 16:05 ET
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the...
May 03, 2024 16:05 ET
Bel Fuse Announces Upcoming Investor Conference Schedule for May 2024
Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, today announced its investor conference schedule for May 2024: Oppenheimer 19th Annual Industrial Growth...
May 03, 2024 16:05 ET
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024, Donald Melnikoff joined electroCore as the Company’s SVP, Engineering, Regulatory, and...
May 03, 2024 16:05 ET
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), a special purpose acquisition company, announced today that it has elected to extend the period of time it has to consummate its initial business combination by one...
May 03, 2024 16:05 ET
Taitron Announces Quarterly Cash Dividend
Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, payable on May 31, 2024 to stockholders of record as of the close of business on...
May 03, 2024 16:05 ET
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS), today announced...
May 03, 2024 16:05 ET
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today...
May 03, 2024 16:01 ET
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 3,800 shares of...
May 03, 2024 16:01 ET
Infinite Reality’s SPAC Partner Engages BTIG as Capital Markets Advisor; Continues to Drive Robust Expansion and Strengthened Market Position
Infinite Reality (“iR” or the “Company”), a leading global provider of cutting-edge virtual, AI-powered immersive experiences, today announced that its previously announced business combination partner, Newbury Street Acquisition Corporation...
May 03, 2024 16:01 ET
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
(TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on June 7, 2024 to unitholders of record on May 31, 2024. For further information, please contact...
May 03, 2024 16:01 ET
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for its ETF Class
(TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.05417 per unit, payable on June 7, 2024 to unitholders of record on May 31, 2024. For further information, please contact...
May 03, 2024 16:01 ET
Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly Distribution
(TSX: XLVE) Mulvihill U.S. Health Care Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on June 7, 2024 to unitholders of record on May 31, 2024. For further information, please contact...
May 03, 2024 16:01 ET
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated...
May 03, 2024 16:01 ET
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages CI&T Inc Investors to Inquire About Securities Class Action Investigation – CINT
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of CI&T Inc (NYSE: CINT) resulting from allegations that CI&T may have issued materially misleading business...
May 03, 2024 16:01 ET
S Split Corp. Declares Monthly Distribution
(TSX: SBN; SBN.PR.A) S Split Corp. has declared monthly distributions, payable on May 31, 2024 to shareholders of record on May 15, 2024. Due to the decline in the net asset value (“NAV”) per unit below $16.50, the Company has suspended...
May 03, 2024 16:01 ET
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on April 30, 2024, the company granted equity awards to ten...
May 03, 2024 16:01 ET
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 31,750 shares of...
May 03, 2024 16:00 ET
OriginTrail Decentralized Knowledge Graph for trusted cross-organization real-time data integration in EU-funded DMaaST
Trace Labs, the core developers of OriginTrail, has joined the European Union's initiative to foster a resilient and adaptive manufacturing ecosystem through the DMaaST project. Collaborating with partners from Slovenia, Spain, Germany,...
May 03, 2024 16:00 ET
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 160,500 restricted stock units of Arcutis’...
May 03, 2024 16:00 ET
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop novel, investigational engineered cytokine therapies designed to address areas...